ARCHIVES

Lapatinib Improves Outcome Of Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 7 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

NCI-Approved Clinical Trials

October 27, 2006

In Turnaround, HHS Says It Will Enforce Pediatric Rule

April 26, 2002

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003